Getting to Know Mary Kunjappu, an Alexion R&D Leading Voice
![Getting to Know Mary Kunjappu, an Alexion R&D Leading Voice](/-/media/alexion_global/images/article-detail-masthead/mary-speaking-with-hand-gestures.png?rev=be6ba21d7ed940018f3418313db55a30)
Science is hard, but rare disease research and development (R&D) stands apart. Because individual patient populations are small and many rare diseases are not well understood, research in this space can often bring added complexity. Mary Kunjappu is a Medical Director in our Medical Affairs team in the US. We spoke with her about the importance of following the science, expecting the unexpected, and the endless possibilities in rare disease research.
How did you get involved in medical affairs?
I'm a bench scientist by training, and towards the end of my PhD, I got very interested in clinical research and the potential for things at the bench to have therapeutic effects. And after graduate school, I started working in medical communications because I was very passionate about talking about the science itself. I started working in rare diseases and I got the opportunity to come in-house with Alexion. I’ve been here for almost seven years now.
![Mary Kunjappu, an Alexion R&D Leading Voice](/-/media/alexion_global/images/full-width-media-item/mary_k_1280x720.jpg?rev=069540b67e594183bafc5450db2992b0)
What led you to a job in rare disease, specifically?
[When] I started working in rare diseases, I really fell in love with the impact it can make and the work that we do for patients and families because many rare diseases are not well known, we get an opportunity to start educating healthcare providers and really, at the early stages, defining different aspects of the disease and what are the symptoms.
What about your work excites you?
I think it gets back to the impact we can make in rare disease where there is often nothing previously existing to help some of these patients, and we’re able to fill that gap. It’s a very unique position to be in.
What’s one lesson you’ve learned from working in rare disease R&D?
It’s all about following the science, even if it takes you to unexpected places. You need to be able to say, “this is where this is leading us, this is what we're learning about this, and the best way for us to understand this molecule,” and be open to making a change.
I’ve learned to really focus on what the information is, and what it is telling us, rather than having preconceived notions of where things should be, and really tailoring and figuring out what the next step should be.
Do you have any advice for someone considering a career in rare disease R&D?
There’re so many new things happening in science that if it doesn't exist today, it may exist tomorrow. Whatever different combination of interests you are thinking about is probably going to happen in the future. Don't limit yourself to what is possible today.
Learn more about our scientists, innovative culture, career opportunities at Alexion.
Share This Page
More articles you may like
Patient Support • June 25, 2024
Getting to know Chathuri Daluwatte, an Alexion R&D Leading Voice
Artificial Intelligence (AI) is rapidly advancing and has the potential to have a transformative impact on clinical research and development (R&D).
Research and Development • June 08, 2024
Getting to know Seng Cheng, an Alexion R&D Leading Voice
There is a sense of urgency that underlies research in rare diseases, because these diseases are often rapidly progressive.
Patient Support • April 18, 2024
Getting to know Sophia Zilber, Associate Director, Statistical Programming
The voices and perspectives of patients play an essential role in rare disease research and development (R&D).
Patient Support • April 16, 2024
Getting to know Banu Sankaran, an Alexion R&D Leading Voice
Diagnostics and artificial intelligence (AI) systems are transforming research and development (R&D) in the healthcare industry.
Health Equity • February 06, 2024
Driving health equity for the rare disease community
Collectively, more than 400 million people around the world are living with a rare disease, defined as conditions that affect a small number of people compared to the general population.
Clinical Trials • November 07, 2023
Understanding & Overcoming the Challenges in Rare Disease Clinical Trials
Why is conducting clinical trials for rare diseases difficult? Because studying a rare disease poses unique challenges and requires thinking differently.
Clinical Trials • November 01, 2023
Getting to know Adrian Kielhorn, an Alexion R&D Leading Voice
Alexion’s leadership in rare disease is driven by the many individuals whose expertise, creativity and tenacity fuel our commitment to advancing innovative science.
Patient Support • June 30, 2023
Children’s Book Series is Inspired By Patients Living with Rare Diseases
At Alexion, our mission is to transform the lives of people affected by rare diseases and one of the tangible ways we raise awareness is by developing tools and resources to educate about the impact of rare diseases on patients, caregivers, and families.